Research indicates a potential relationship between fatty liver, kidney stones, and gallstones due to shared metabolic risk factors. More studies are required to validate these findings across different populations.
Studies suggest that curcumin for fatty liver improves liver enzyme levels, reduces fibrosis, and has cardiovascular benefits. Although promising, more extensive trials are needed to validate its effectiveness as a long-term treatment option.
Primary biliary cholangitis is a rare liver disease causing bile duct damage. New therapies like seladelpar improve outcomes for treatment-resistant patients, offering better symptom management.
Oral contraceptives may be linked to fatty liver. Avoid alcohol, smoking, and sedentary lifestyles to reduce the risk.
A new treatment for chronic hepatitis B using an antisense probe shows promising results, with 62% achieving theoretical cure and mild side effects.
Two recent studies reveal that Survodutide and Tirzepatide significantly improve the treatment of fatty liver by reducing fibrosis and enhancing liver health.
A novel hydrogel can prevent alcohol toxicity, showing effectiveness in studies with mice.
Coffee and grape seed extract may help treat fatty liver and improve cardiovascular and metabolic health. More studies are needed to confirm these results.
Alcohol worsens fatty liver, significantly increasing mortality in high-risk patients, even with moderate intake
Recent study highlights aldafermin’s ability to reverse liver cirrhosis due to fatty liver by reducing fibrosis in patients. A significant breakthrough in treatment prospects.